(R)-3-Amino-3-(4-fluorophenyl)propanoic acid is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its chiral structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting neurological and psychiatric disorders. The compound is often employed in the production of inhibitors for enzymes like GABA transaminase, which play a role in regulating neurotransmitters in the brain. Additionally, it serves as a building block in the creation of peptide-based therapeutics, where its fluorine substitution enhances metabolic stability and binding affinity. Its applications also extend to research settings, where it is utilized in studying the structure-activity relationships of drug candidates.